Charles Schwab Investment Management »

Telomir Pharmaceuticals shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Telomir Pharmaceuticals (TELO) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Telomir Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Telomir Pharmaceuticals held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Telomir Pharmaceuticals by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $52k 11k 4.81

More positions owned by Charles Schwab Investment Management

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Schwab Strategic Tr Fundamental Us L (FNDX)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Alphabet Cap Stk Cl C (GOOG)
Schwab Strategic Tr Fundamental Us S (FNDA)
Schwab Strategic Tr 5 10yr Corp Bd (SCHI)
Broadcom (AVGO)
Schwab Strategic Tr Fundamental Intl (FNDF)
Home Depot (HD)

View all positions for Charles Schwab Investment Management

Top funds holding Telomir Pharmaceuticals

BlackRock
Geode Capital Management
Bank of New York Mellon
Vanguard Group
Suncoast Equity Management
New York State Common Retirement Fund
State Street Corporation
Beaird Harris Wealth Management
Charles Schwab Investment Management
Citigroup
Morgan Stanley
Rhumbline Advisers
Bank of America Corporation
Jpmorgan Chase & Co
Wells Fargo & Company

View all funds holding Telomir Pharmaceuticals